Filing Flows › ClearPoint Neuro (CLPT) › Q2 2025
ClearPoint Neuro (CLPT) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
ClearPoint Neuro (CLPT) reported revenue of $9.2M for the second quarter 2025 (Q2 2025), +17% from a year earlier and +9% from the quarter before. Operating margin was -61.6%, net loss $5.8M (63.3% of revenue).
ClearPoint Neuro, Q2 2025: revenue $9.2M (+17% year over year), operating margin -61.6%, net loss $5.8M, operating cash flow −$2.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.2M | +9% | +17% |
| Operating profit | −$5.7M | — | — |
| Net earnings | −$5.8M | — | — |
| Operating cash flow | −$2.6M | — | — |
What changed
Revenue was $9.2M in Q2 2025, up 17% year over year and up 9% from the previous quarter. Service was the largest line at 35% of revenue. Service added $304K year over year (up 10%), 22% of the total change. Capital Equipment Related Service Revenue declined 60%.
Gross margin was 60.3%, down 3.2 points from a year earlier. Operating costs exceeded revenue by $5.7M, an operating margin of -61.6%. Operating expenses grew 16% against revenue growth of 17%. The fastest-growing cost line was SG&A (+23%). The quarter ended with a net loss of $5.8M, narrower than the previous quarter's $6.0M loss.
Operating cash flow was −$2.6M. Non-cash charges added back $396K of depreciation and amortization and $2.3M of share-based compensation. Working capital and other items added $620K. Capital expenditures of $91K exceeded it, leaving free cash flow of −$2.6M.
Questions
What was ClearPoint Neuro's revenue in the second quarter 2025?
ClearPoint Neuro (CLPT) reported revenue of $9.2M for the second quarter 2025 (Q2 2025), +17% from a year earlier and +9% from the quarter before.
Was ClearPoint Neuro profitable in the second quarter 2025?
Operating loss was $5.7M (-61.6% of revenue) and net loss $5.8M.
Source: ClearPoint Neuro 10-Q on SEC EDGAR.